All In MedTech

Device Trial Radar · NCT00731640

Contralateral ReSTOR / Monofocal or Phakic Eye

Clinical Outcomes With AcrySof ReSTOR Aspheric Apodized Diffractive Intraocular Lens (IOL) in One Eye and a Contralateral Monofocal IOL or Phakic Eye

Last checked: Nov 20, 2026Latest source record: Mar 23, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

52

Actual

Start

Jun 2007

Primary completion

May 2008

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Aug 11, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Bilateral evaluation of unilateral implantation of ReSTOR and contralateral monofocal or phakic eye.

Conditions

  • Cataracts

Interventions

  • ReSTORDevice

    AcrySof ReSTOR +4 Intraocular Lens (IOL) unilaterally implanted

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual AcuityTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Alcon Call Center for Trial Locations

    Fort Worth, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.